Profusa (PFSA) Liabilities and Shareholders Equity (2021 - 2026)
Profusa (PFSA) posted quarterly Liabilities and Shareholders Equity of $862000.0 for Q1 2026, down 56.54% year-over-year from $2.0 million in Q1 2025, and down 77.17% quarter-over-quarter from $3.8 million in Q4 2025.
Profusa (PFSA) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends
Profusa's Liabilities and Shareholders Equity history runs 6 years deep, the most recent figure standing at $862000.0 for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity fell 56.54% year-over-year to $862000.0; the TTM figure through Mar 2026 stood at $10.8 million (down 51.63% YoY), while the FY2025 annual figure was $3.8 million, up 22.84% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $862000.0, down from $3.8 million in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $194.7 million in Q4 2022, with the low at $862000.0 in Q1 2026.
- The 5-year median for Liabilities and Shareholders Equity is $8.8 million (2024), against an average of $50.6 million.
- The sharpest annual moves came in 2023 and 2025: Liabilities and Shareholders Equity sank 94.43% in 2023, then gained 22.84% in 2025.
- Profusa's Liabilities and Shareholders Equity stood at $194.7 million in 2022, then plunged by 94.41% to $10.9 million in 2023, then slumped by 71.77% to $3.1 million in 2024, then climbed by 22.84% to $3.8 million in 2025, then sank by 77.17% to $862000.0 in 2026.
- Business Quant data shows PFSA's Liabilities and Shareholders Equity at $862000.0 in Q1 2026, $3.8 million in Q4 2025, and $4.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 47.93 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 13.87 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 6.46 Bn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 37.25 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 31.04 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Profusa | 92,085.85 | -282,914.15 | - | 862,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 862,000.00 |
| Dec 31, 2025 | 3.78 Mn |
| Sep 30, 2025 | 4.25 Mn |
| Jun 30, 2025 | 1.96 Mn |
| Mar 31, 2025 | 1.98 Mn |
| Dec 31, 2024 | 3.07 Mn |
| Sep 30, 2024 | 8.78 Mn |
| Jun 30, 2024 | 8.59 Mn |
| Mar 31, 2024 | 8.50 Mn |
| Dec 31, 2023 | 10.88 Mn |
| Sep 30, 2023 | 10.80 Mn |
| Jun 30, 2023 | 10.90 Mn |
| Mar 31, 2023 | 10.74 Mn |
| Dec 31, 2022 | 194.74 Mn |
| Sep 30, 2022 | 193.79 Mn |
| Jun 30, 2022 | 192.86 Mn |
| Mar 31, 2022 | 192.87 Mn |
| Dec 31, 2021 | 193.06 Mn |